Načítá se...
Reduced Intensity Hematopoietic-cell Transplantation in Older Patients with AML/MDS: Umbilical Cord Blood is a Feasible Option for Patients without HLA-matched Sibling Donors
Umbilical cord blood (UCB) has increased access to hematopoietic-cell transplantation (HCT) for patients without HLA-matched sibling donors (MSD). We compared outcomes of HCT using MSD (N=38) or UCB (N=60) among older patients (age ≥55 years) with acute myeloid leukemia (AML) or myelodysplastic synd...
Uloženo v:
Hlavní autoři: | , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
2011
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4107640/ https://ncbi.nlm.nih.gov/pubmed/21602900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2011.114 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|